Price Chart

Profile

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer’s disease, INM-089’s pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
URL https://www.inmedpharma.com
Investor Relations URL http://www.inmedpharma.com/s/stock-info.asp
HQ State/Province British Columbia
Sector Health Care
Industry Pharmaceuticals
Equity Style Small Cap/Value
Next Earnings Release Feb. 13, 2025 (est.)
Last Earnings Release Nov. 14, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer’s disease, INM-089’s pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
URL https://www.inmedpharma.com
Investor Relations URL http://www.inmedpharma.com/s/stock-info.asp
HQ State/Province British Columbia
Sector Health Care
Industry Pharmaceuticals
Equity Style Small Cap/Value
Next Earnings Release Feb. 13, 2025 (est.)
Last Earnings Release Nov. 14, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A